BRD4 and MYC were found to be expressed in primary CML cells, CD34+/CD38− leukemic stem cells (LSC), and in the CML cell lines KU812, K562, KCL22, and KCL22T315I. The gene discussed is BRD4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.